|
PureBytes Links
Trading Reference Links
|
Yes I feel strong. I have everything on the line. Credit cards
included.
Its based on fundamentals
and 'sex appeal'.
Zicam reduces the common cold to 1 1/2 days.
Money spent in the USA on otc remedies in $2.5 Billion/year.
ZICAM is just in the first year of penetrating this market.
Orders are already coming in from other countries for the product.
http://www.gumminvestors.com -- investor website * * * please address
futher questions here
The growth potential is nearly unlimmited.
Why this is a neat investment is because its just a small company with
very
few shares and when you make a lot of money compared with the few
shares,
the earnings growth becomes spectacular.
The gum formulator is THE world expert on chewing gum. In a few years
we'll
see some gums with prescription drugs in them that will be money makers
and
catapult the company's revenues further.
This is just the start. And I'm happy to share my vision with others.
What is just around the corner? Many news releases that will bring
further
attraction for more buyers.
And other possibilities of other pharma recognizing the possibilities of
Chewing Gum as a drug Delivery.
Right now the uproar is zicam, as it should, but there's a lot more than
that on the way.
You brought the concern of no need for Zicam during certain parts of the
year. Guess what?
They are going after the allergy market as well, but those studies won't
be
complete until next Spring.
Also, zicam will be treating colds in other parts of the world where its
summer here and winter there.
Here is the company Web Site: http://www.gum-tech.com/first.html
Play around there and see the products they make for other companies
etc.
The big money is coming from having the number 1 Remedy for the common
cold. -- that's the 'sex appeal'
Be glad to answer any other questions you have.
Thanks for showing some interest.
Layne
----- Original Message -----
From: <itradesp@xxxxxxxxxxxx>
To: Dr. Hermansen <lahermansen@xxxxxxxxxxxxx>
Sent: Wednesday, November 10, 1999 12:18 AM
Subject: Re: Medical Stock - update
> Do you feel really strong about this one? I'm wondering how the
> stock will do after the winter is over. I live in New England and it's
> obvious there wouldn't be a need for this product in the late spring,
> summer and early fall months. Look forward to hearing from you.
>
> Matt Andrews
>
>
> Date sent: Tue, 9 Nov 1999 23:16:53 -0500
> From: "Dr. Hermansen" <lahermansen@xxxxxxxxxxxxx>
> To: <omega-list@xxxxxxxxxx>
> Subject: Medical Stock - update
>
> Most everyone now knows the name of the stock and product.
>
> Zicam reached the front Page of USA TODAY. - lots of free advertising
and
> it launched the product right off the shelves of 50,000 stores in the
USA.
> (that upset the journal who was going to publish the study, ) or was
it a
> Guerrilla tactic?
> http://biz.yahoo.com/prnews/990901/az_gel_tec_1.html
>
> We can now reduce our common colds to 1 1/2 days. ..... with that
news,
> ZICAM has been literally sold out in all stores.
>
> Here is an UPDATE ON GUMM --- excellent !
>
> * * http://www.siliconinvestor.com/stocktalk/msg.gsp?msgid=11853572
>
> last week alone, roughly 600,000 units were ordered from stores caught
> without ZICAM.
>
> $1.75 is the net profit for GUMM per unit.
>
> Next news:
> Nicotine Gum worldwide == that is what the company said at
shareholders
> meeting == big international company.
>
> If you live in a country outside the USA, go to http://www.ZICAM.com
to
> order the product online.
> Next year ZICAM should be available internationally.
>
> *************
>
>
|